Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Asklepios BioPharmaceutical, Inc.

https://www.askbio.com/

Latest From Asklepios BioPharmaceutical, Inc.

J.P. Morgan Day Four: Talking With Execs About BD Plans

Daily notebook from the J.P. Morgan Healthcare Conference: Big pharma execs weigh in on business development strategy, Sage CEO Barry Green discusses how the Inflation Reduction Act should spur deal-making and bluebird talks about gene therapy commercialization plans. 

Deals Growth

J.P. Morgan Day Three: 2023 Is A Year Of Commercial Challenges

Daily notebook from the J.P. Morgan Healthcare Conference: Gene therapy Vertex enters pricing negotiations on gene therapy, Sanofi sees opportunity in hemophilia despite new gene therapy, and AbbVie raises guidance ahead of the introduction of Humira biosimilars. Plus ICER's Steven Pearson and former Biogen CEO George Scangos weigh in on Alzheimer's developments. 

Gene Therapy Launches

Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players

As the usual flurry of deals coincides with the J.P. Morgan Healthcare Conference, AbbVie signed an mRNA pact with Anima and a cancer research tie-up with Immunome.

Deal Watch Business Strategies

The E In ESG: An Opportunity For The Medtech Industry

Can environmental sustainability become a business differentiator? Some companies are already onto it. Boston Consulting Group puts the case in favor of the argument.

Medical Device Sustainability
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Tools
      • Bioinformatics
  • Other Names / Subsidiaries
    • Actus Therapeutics, Inc.
    • AskBio
    • Synpromics, Ltd.
    • RoverMed BioSciences
    • NanoCor Therapeutics
    • BrainVectis
UsernamePublicRestriction

Register